Company Number: 15880531

Analysis Date: 2025-07-29 16:08 UTC

Financial Health Assessment of CAROMARK LIMITED

---

1. Financial Health Score: B

Explanation:
CAROMARK LIMITED, being a newly incorporated small private limited company, shows early signs of stable financial health with positive working capital and shareholders’ funds. The company is not burdened by overdue filings or legal distress. However, as it is in its first financial year and has limited financial history, the score reflects good initial health but also acknowledges the early stage risks and limited operational track record.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Assets	22,061	Indicates liquid resources including cash and receivables available to cover short-term debts
Cash	9,522	Healthy cash reserve providing liquidity to meet immediate obligations
Debtors	12,539	Amount owed by customers; moderate size relative to cash, needs to be monitored for collection
Current Liabilities	19,304	Short-term debts and obligations due within one year
Net Current Assets (Working Capital)	2,757	Positive but modest; indicates ability to cover short-term liabilities, though margin is narrow
Fixed Assets (Tangible)	2,385	Investment in long-term assets supporting operations
Shareholders’ Funds (Equity)	5,142	Positive equity base indicating net worth; important for business solvency
Dividends Paid	20,000	Distributions to directors despite modest profits; potential drain on cash flow if repeated
Director Loan	10,689	Loan from director included in creditors, showing reliance on related party financing

---

3. Diagnosis

CAROMARK LIMITED is showing a healthy financial pulse for a start-up in its first reporting period. The company has generated assets and has more current assets than current liabilities, indicating a positive working capital "heartbeat." Cash levels are sufficient for immediate needs, reducing liquidity stress symptoms.

However, the relatively narrow buffer in net current assets suggests a fragile financial condition that could become strained if receivables are delayed or unexpected costs arise. The company’s reliance on director loans reflects early-stage financing strategies and should be closely monitored to avoid liquidity imbalances.

The payment of £20,000 in dividends during the first period, despite modest reserves, may signal aggressive profit distribution which could weaken the company’s cash reserves and resilience to operational fluctuations.

No audit was required or performed, common for small companies, but this limits external verification of financial health.

Overall, the company exhibits no signs of distress or insolvency but remains in a delicate phase typical of start-ups, where careful cash flow management and growth monitoring are critical.

---

4. Recommendations

1. Enhance Cash Flow Management:
   Maintain or increase cash reserves to strengthen the liquidity buffer. Avoid distributions such as dividends until a consistent and sustainable profit pattern emerges.

2. Monitor Debtor Collection:
   Implement robust credit control procedures to ensure timely collection of outstanding receivables (£12,539) to prevent cash flow strain.

3. Formalize Director Loan Terms:
   Clarify and document the terms of director loans to manage repayment schedules and avoid liquidity surprises.

4. Build Financial Reserves:
   Retain earnings within the business initially to build up profit and loss reserves, improving equity and financial resilience.

5. Regular Financial Reviews:
   Institute quarterly financial health checks focusing on working capital, cash flow forecasts, and creditor management to detect early symptoms of financial stress.

6. Plan for Growth:
   Consider strategic planning for scaling operations, including potential capital injections or external financing as the business expands.

---